Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2025)

Amphastar Pharmaceuticals (AMPH) has 7 years of Current Leases data on record, last reported at $7.8 million in Q3 2025.

  • For Q3 2025, Current Leases rose 85.96% year-over-year to $7.8 million; the TTM value through Sep 2025 reached $7.8 million, up 85.96%, while the annual FY2024 figure was $6.8 million, 74.19% up from the prior year.
  • Current Leases reached $7.8 million in Q3 2025 per AMPH's latest filing, down from $7.9 million in the prior quarter.
  • Across five years, Current Leases topped out at $7.9 million in Q2 2025 and bottomed at $2.9 million in Q3 2021.
  • Average Current Leases over 5 years is $4.3 million, with a median of $3.7 million recorded in 2021.
  • Peak YoY movement for Current Leases: fell 21.35% in 2021, then skyrocketed 97.17% in 2025.
  • A 5-year view of Current Leases shows it stood at $3.0 million in 2021, then rose by 0.7% to $3.0 million in 2022, then soared by 30.07% to $3.9 million in 2023, then surged by 74.19% to $6.8 million in 2024, then rose by 15.04% to $7.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $7.8 million in Q3 2025, $7.9 million in Q2 2025, and $7.7 million in Q1 2025.